IP Library › Granted Patent US 12,044,681
Granted Patent B2
US 12,044,681 · App. 17/372,575 · Granted Jul 23, 2024

Protein signatures for distinguishing between bacterial and viral infections

Inventors: Eran Eden (Haifa, IL); Kfir Oved (Hof HaCarmel, IL); Assaf Cohen-Dotan (Natania, IL); Roy Navon (Tel-Aviv, IL); Olga Boico (Atlit, IL); Gali Kronenfeld (Tirat Carmel, IL); Meital Paz (Haifa, IL); Ellen Bamberger (Haifa, IL)
Assignee: MeMed Diagnostics Ltd.
G01N33/56911C07K14/525C07K14/5412C07K14/555C07K14/57527C07K16/12C07K16/18C07K16/241C07K16/248C07K16/249C07K16/26C07K16/2818C07K16/2875G01N33/5091G01N33/52G01N33/53G01N33/535G01N33/54306G01N33/547G01N33/577G01N33/581G01N33/582G01N33/60G01N33/6863G01N33/6869G01N33/6893G16B40/20G16B40/30G01N2333/525G01N2333/5412G01N2333/555G01N2333/5753G01N2333/585G01N2333/70578G01N2333/70596G01N2333/7155G01N2333/902G01N2333/916G01N2469/00G01N2800/122G01N2800/26G16B20/00G16B40/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,044,681
App. No.
17/372,575
Granted
Jul 23, 2024
Kind
B2
Abstract

Methods of diagnosing infections are disclosed. In one embodiment, the method comprises measuring the amount of each of the polypeptides TRAIL, CRP, IP10 and at least one additional polypeptide selected from the group consisting of IL-6 and PCT.

Claims (22)

1. A kit for distinguishing between a viral and a bacterial infection using a blood sample of a subject comprising:

(i) an antibody which specifically detects TNF-related apoptosis-inducing ligand (TRAIL);

(ii) an antibody which specifically detects Interleukin-6 (IL-6):

(iii) an antibody which specifically detects C-reactive protein (CRP); and

(iv) an antibody which specifically detects Interferon gamma-induced protein 10 (IP10), wherein the kit comprises antibodies that specifically detect no more than 5 proteins, wherein at least one of said antibodies is attached to a detectable label or a solid support.

2. The kit of claim 1 , comprising antibodies which specifically detect said TRAIL, said IP10, said CRP, said IL-6 and Procalcitonin (PCT).

3. The kit of claim 1 , wherein each of said antibodies are attached to a detectable moiety.

4. The kit of claim 1 , wherein each of said antibodies are attached to a solid support.

5. The kit of claim 1 , wherein the antibodies of the kit consist of:

(i) said antibody which specifically detects TRAIL;

(ii) said antibody which specifically detects IL-6:

(iii) said antibody which specifically detects CRP; and

(iv) said antibody which specifically detects IP10.

6. The kit of claim 1 , wherein the antibodies of the kit consist of:

(i) said antibody which specifically detects TRAIL;

(ii) said antibody which specifically detects IL-6;

(iii) an antibody which specifically detects PCT;

(iii) said antibody which specifically detects CRP; and

(iv) said antibody which specifically detects IP10.

7. The kit of claim 1 , wherein said detectable label is selected from the group consisting of a radioactive label, a fluorescent label, a chemiluminescent label, a colorimetric label and an enzyme.

8. The kit of claim 7 , wherein said enzyme is horseradish peroxidase or alkaline phosphatase.

9. The kit of claim 1 , wherein at least one of said antibodies is a monoclonal antibody.

Assignments (2)
SECURITY INTEREST Recorded Mar 11, 2026
From: MEMED DIAGNOSTICS LTD.
To: WTI FUND X, INC.; WTI FUND XI, INC.
Reel/Frame 074048/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2021
From: EDEN, ERAN; OVED, KFIR; COHEN-DOTAN, ASSAF; NAVON, ROY; BOICO, OLGA; KRONENFELD, GALI; PAZ, MEITAL; BAMBERGER, ELLEN
To: MEMED DIAGNOSTICS LTD.
Reel/Frame 056875/0257 →
Continuity (4)
Continuation 16238582 · Jan 3, 2019
Continuation PCTIL2017050780 · Jul 10, 2017
Provisional Application 62360418 · Jul 10, 2016
Related Publication 20220011320A1 · Jan 13, 2022